Recurrence of Esophageal Intestinal Metaplasia After Endoscopic Mucosal Resection and Radiofrequency Ablation of Barrett's Esophagus: Results From a US Multicenter Consortium

被引:172
|
作者
Gupta, Milli [1 ]
Iyer, Prasad G. [1 ]
Lutzke, Lori [1 ]
Gorospe, Emmanuel C. [1 ]
Abrams, Julian A. [2 ]
Falk, Gary W. [3 ]
Ginsberg, Gregory G. [3 ]
Rustgi, Anil K. [3 ]
Lightdale, Charles J. [2 ]
Wang, Timothy C. [2 ]
Fudman, David I. [2 ]
Poneros, John M. [2 ]
Wang, Kenneth K. [1 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Columbia Univ, Med Ctr, Div Digest & Liver Dis, New York, NY USA
[3] Univ Penn, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
Esophageal Cancer; Prevention; Endoscopic Therapy; EAC; HIGH-GRADE DYSPLASIA; FOCAL ABLATION; EARLY NEOPLASIA; ERADICATION; ADENOCARCINOMA; SURVEILLANCE; REGISTRY;
D O I
10.1053/j.gastro.2013.03.008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Radiofrequency ablation (RFA) is an established treatment for dysplastic Barrett's esophagus (BE). Although short-term end points of ablation have been ascertained, there have been concerns about recurrence of intestinal metaplasia (IM) after ablation. We aimed to estimate the incidence and identify factors that predicted the recurrence of IM after successful RFA. METHODS: We analyzed data from 592 patients with BE treated with RFA from 2003 through 2011 at 3 tertiary referral centers. Complete remission of intestinal metaplasia (CRIM) was defined as eradication of IM (in esophageal and gastroesophageal junction biopsy specimens), documented by 2 consecutive endoscopies. Recurrence was defined as the presence of IM or dysplasia after CRIM in surveillance biopsies. Two experienced gastrointestinal pathologists confirmed pathology findings. RESULTS: Based on histology analysis, before RFA, 71% of patients had high-grade dysplasia or esophageal adenocarcinoma, 15% had low-grade dysplasia, and 14% had nondysplastic BE. Of patients treated, 448 (76%) were assessed after RFA. Fifty-five percent of patients underwent endoscopic mucosal resection before RFA. The median time to CRIM was 22 months, with 56% of patients in CRIM by 24 months. Increasing age and length of BE segment were associated with longer times to CRIM. Twenty-four months after CRIM, the incidence of recurrence was 33%; 22% of all recurrences observed were dysplastic BE. There were no demographic or endoscopic factors associated with recurrence. Complications developed in 6.5% of subjects treated with RFA; strictures were the most common complication. CONCLUSIONS: Of patients with BE treated by RFA, 56% were in complete remission after 24 months. However, 33% of these patients had disease recurrence within the next 2 years. Most recurrences were nondysplastic and endoscopically manageable, but continued surveillance after RFA is essential.
引用
收藏
页码:79 / +
页数:9
相关论文
共 50 条
  • [41] Radiofrequency ablation and endoscopic mucosal resection in Barrett's esophagus with early neoplasia. Can we avoid complications?
    Conio, M.
    Fisher, D. A.
    Palazzo, L.
    ENDOSCOPY, 2013, 45 (06) : 506 - 506
  • [42] Dysplasia Recurrence After Complete Eradication of Intestinal Metaplasia (CEIM) and Dysplasia (CED) in Barrett's Esophagus Treated With Endoscopic Therapy: Results From an International, Multi-Center Consortium
    Krishnamoorthi, Rajesh
    Vennelaganti, Sreekar
    Repici, Alessandro
    Konda, Vani J.
    Waxman, Irving
    Seewald, Stefan
    Stier, Matthew W.
    Haidry, Rehan
    Buckles, Daniel
    Gupta, Neil
    Bansal, Ajay
    Mathur, Sharad
    Olyaee, Mojtaba S.
    Bourke, Michael J.
    Falk, Gary W.
    Jegadeesan, Ramprasad
    Nguyen, Julie
    Vennalaganti, Prashanth
    Vittal, Anusha
    Kennedy, Kevin F.
    Sharma, Prateek
    Ross, Andrew S.
    GASTROINTESTINAL ENDOSCOPY, 2017, 85 (05) : AB77 - AB78
  • [43] Esophageal Mucosal Impedance Measurement During Endoscopy: A New Approach to Diagnosis and Confirmation of Complete Remission of Intestinal Metaplasia Following Radiofrequency Ablation in Barrett's Esophagus
    Schnoll-Sussman, Felice
    Katz, Philip
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S222 - S223
  • [44] What Is the Histology of Subsquamous Intestinal Metaplasia (SSIM) in Patients With Prior Radiofrequency Ablation (RFA) for Treatment of Barrett's Esophagus (BE)? Results From the US RFA Registry
    Hathorn, Kelly E.
    Bulsiewicz, William J.
    Pruitt, Ronald E.
    Chmielewski, Gary W.
    Madanick, Ryan D.
    Corbett, F. Scott
    Rothstein, Richard I.
    Lightdale, Charles J.
    Triadafilopoulos, George
    Shaheen, Nicholas J.
    GASTROENTEROLOGY, 2013, 144 (05) : S377 - S377
  • [45] Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial
    Cotton, Cary C.
    Wolf, W. Asher
    Overholt, Bergein F.
    Li, Nan
    Lightdale, Charles J.
    Wolfsen, Herbert C.
    Pasricha, Sarina
    Wang, Kenneth K.
    Shaheen, Nicholas J.
    GASTROENTEROLOGY, 2017, 153 (03) : 681 - +
  • [46] Efficacy of Radiofrequency Ablation Combined With Endoscopic Resection for Barrett's Esophagus With Early Neoplasia
    Pouw, Roos E.
    Wirths, Katja
    Eisendrath, Pierre
    Sondermeijer, Carine M.
    Ten Kate, Fiebo J.
    Fockens, Paul
    Deviere, Jacques
    Neuhaus, Horst
    Bergman, Jacques J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (01) : 23 - 29
  • [47] Factors Associated With Recurrence of Barrett's Esophagus After Completion of Radiofrequency Ablation
    Shue, Peter
    Kataria, Rahul
    Pathikonda, Murali
    Friedenberg, Frank K.
    Thomas, Rebecca
    Smith, Michael S.
    GASTROENTEROLOGY, 2013, 144 (05) : S697 - S697
  • [48] Safety and Outcomes of Radiofrequency Ablation for Barrett's Esophagus in Older Subjects: Results From a BETRNet Consortium
    Gupta, Milli
    Lutzke, Lori S.
    Wang, Kenneth K.
    Abrams, Julian A.
    Wang, Timothy C.
    Lightdale, Charles J.
    Falk, Gary W.
    Ginsberg, Gregory G.
    Rustgi, Anil K.
    Poneros, John M.
    Leggett, Cadman
    Nelsen, Eric M.
    Prasad, Ganapathy A.
    GASTROINTESTINAL ENDOSCOPY, 2012, 75 (04) : 159 - 159
  • [49] ESOPHAGEAL ENDOSCOPIC MUCOSAL RESECTION (EMR) PREFERENCES AMONG BARRETT'S ESOPHAGUS EXPERTS
    Tofani, Christina J.
    Amer, Kamal
    Elden, Andrew C.
    Infantolino, Anthony
    GASTROINTESTINAL ENDOSCOPY, 2019, 89 (06) : AB470 - AB471
  • [50] Predictors of recurrent Barrett's esophagus after successful radiofrequency ablation in a nationwide, multicenter cohort: Results from the US RFA Registry.
    Bulsiewicz, William J.
    Dellon, Evan S.
    Lyday, William D.
    Ertan, Atilla
    Camara, Daniel S.
    Komanduri, Srinadh
    Chmielewski, Gary W.
    Muthusamy, V. Raman
    Shaheen, Nicholas J.
    GASTROENTEROLOGY, 2013, 144 (05) : S1 - S1